Support Center for Advanced Neuroimaging, University Institute for Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Support Center for Advanced Neuroimaging, University Institute for Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Neuroimage Clin. 2020;25:102104. doi: 10.1016/j.nicl.2019.102104. Epub 2019 Dec 9.
The detection of new or enlarged white-matter lesions is a vital task in the monitoring of patients undergoing disease-modifying treatment for multiple sclerosis. However, the definition of 'new or enlarged' is not fixed, and it is known that lesion-counting is highly subjective, with high degree of inter- and intra-rater variability. Automated methods for lesion quantification, if accurate enough, hold the potential to make the detection of new and enlarged lesions consistent and repeatable. However, the majority of lesion segmentation algorithms are not evaluated for their ability to separate radiologically progressive from radiologically stable patients, despite this being a pressing clinical use-case. In this paper, we explore the ability of a deep learning segmentation classifier to separate stable from progressive patients by lesion volume and lesion count, and find that neither measure provides a good separation. Instead, we propose a method for identifying lesion changes of high certainty, and establish on an internal dataset of longitudinal multiple sclerosis cases that this method is able to separate progressive from stable time-points with a very high level of discrimination (AUC = 0.999), while changes in lesion volume are much less able to perform this separation (AUC = 0.71). Validation of the method on two external datasets confirms that the method is able to generalize beyond the setting in which it was trained, achieving an accuracies of 75 % and 85 % in separating stable and progressive time-points.
检测新的或扩大的脑白质病变是对接受疾病修饰治疗的多发性硬化症患者进行监测的重要任务。然而,“新的或扩大的”的定义并不固定,已知病灶计数具有高度的主观性,存在高度的观察者内和观察者间变异性。如果定量病变的自动化方法足够准确,则有可能使新病变和扩大病变的检测具有一致性和可重复性。然而,尽管这是一个紧迫的临床用例,但大多数病变分割算法并没有针对其将影像学进展患者与影像学稳定患者区分开来的能力进行评估。在本文中,我们探讨了深度学习分割分类器通过病变体积和病变计数来区分稳定和进展患者的能力,发现这两种方法都不能很好地区分。相反,我们提出了一种识别高确定性病变变化的方法,并在多发性硬化症的纵向病例内部数据集上建立了该方法,该方法能够非常高的区分度(AUC = 0.999)将进展和稳定时间点区分开来,而病变体积的变化则很难进行这种区分(AUC = 0.71)。在两个外部数据集上对该方法进行验证,证实了该方法能够在训练环境之外进行推广,在区分稳定和进展时间点方面的准确率分别达到 75%和 85%。